Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 57% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 28408.02 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 8449.16 | 832 / 861 | 0% | 0 | 0 / 0 |
skin | 20% | 565.13 | 357 / 1809 | 9% | 0.40 | 43 / 472 |
prostate | 6% | 80.49 | 14 / 245 | 5% | 0.41 | 26 / 502 |
adrenal gland | 2% | 7.15 | 4 / 258 | 8% | 0.46 | 19 / 230 |
esophagus | 2% | 18.08 | 32 / 1445 | 5% | 0.12 | 9 / 183 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.63 | 3 / 45 |
pancreas | 1% | 7.49 | 4 / 328 | 5% | 0.09 | 9 / 178 |
uterus | 0% | 0 | 0 / 170 | 6% | 0.94 | 26 / 459 |
breast | 1% | 13.78 | 5 / 459 | 4% | 0.29 | 40 / 1118 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.32 | 23 / 504 |
stomach | 0% | 0 | 0 / 359 | 4% | 0.06 | 11 / 286 |
lung | 0% | 8.56 | 2 / 578 | 2% | 0.15 | 27 / 1155 |
intestine | 0% | 0.44 | 1 / 966 | 2% | 0.07 | 8 / 527 |
blood vessel | 1% | 34.07 | 20 / 1335 | 0% | 0 | 0 / 0 |
thymus | 1% | 7.83 | 5 / 653 | 0% | 0.03 | 3 / 605 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 6 / 901 |
peripheral blood | 1% | 6.86 | 6 / 929 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.01 | 2 / 430 |
adipose | 0% | 1.96 | 5 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0.73 | 5 / 2642 | 0% | 0.01 | 1 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045214 | Biological process | sarcomere organization |
GO_0007411 | Biological process | axon guidance |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0070593 | Biological process | dendrite self-avoidance |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030424 | Cellular component | axon |
GO_0031674 | Cellular component | I band |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0030018 | Cellular component | Z disc |
GO_0005634 | Cellular component | nucleus |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_0051371 | Molecular function | muscle alpha-actinin binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | MYPN |
Protein name | Myopalladin Alternative protein MYPN Myopalladin (145 kDa sarcomeric protein) MYPN protein (Myopalladin) |
Synonyms | MYOP |
Description | FUNCTION: Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines. . |
Accessions | ENST00000685154.1 ENST00000358913.10 [Q86TC9-1] ENST00000689484.1 ENST00000685006.1 A0A8I5KSE3 ENST00000613327 A0A8I5KRJ0 A0A8I5KWT3 A0A8I5QKN9 ENST00000354393.7 [Q86TC9-2] ENST00000692038.1 ENST00000690544.1 ENST00000687705.1 ENST00000692979.1 ENST00000685627.1 L8ECL4 ENST00000540630.6 A0A087WX60 A0A8I5KX00 A0A8I5KW69 A0A8I5KVD9 A0A804CFL5 A0A8J9ASZ5 ENST00000373675.4 ENST00000688812.1 ENST00000693699.1 L8EAK0 A0A8I5KT31 ENST00000613327.5 [Q86TC9-1] ENST00000689797.1 A0A8I5QL13 Q86TC9 ENST00000687572.1 A0A8I5KV65 |